SOFA评分早期变化作为脓毒症28天死亡率预后标志物:衍生与验证队列分析
该研究基于两项已发表的随机对照试验数据,以严重革兰阴性感染患者为衍生队列(448例),呼吸机相关性肺炎患者为验证队列(199例),仅纳入符合Sepsis-3定义的脓毒症患者。SOFA评分在第1、2、3、5、7、14、28天计算。衍生队列中ΔSOFA预测死亡率最早的时间点为第7天(AUROC 0.84,95%CI 0.80-0.89,P<0.001),最佳预测界值为25%变化(敏感性78%,特异性80%);入组SOFA下降不足25%与死亡率升高相关(死亡比值比14.87),该发现在验证队列中得到确认。作者认为第7天ΔSOFA是有用的早期预后标志物,可作为未来脓毒症试验与死亡率并列的终点指标。
要点
- 衍生队列第7天ΔSOFA预测28天死亡率AUROC 0.84(95%CI 0.80-0.89,P<0.001)。
- 最佳预测界值为SOFA变化25%:敏感性78%,特异性80%。
- 入组SOFA下降不足25%与死亡风险升高相关,死亡比值比14.87。
- 该发现在验证队列(199例,28天死亡率29.6%)中得到确认。
- 作者认为第7天ΔSOFA可作为未来脓毒症试验与死亡率并列的终点指标。
适用人群与场景
- 两项已发表随机对照试验中的患者:衍生队列为严重革兰阴性感染患者448例,验证队列为呼吸机相关性肺炎患者199例。
- 仅纳入符合Sepsis-3定义的脓毒症患者。
诊断标准与关键阈值
- 脓毒症诊断采用Sepsis-3定义。
- SOFA评分在第1、2、3、5、7、14、28天计算。
- ΔSOFA预测28天死亡率的最佳界值为SOFA变化25%(敏感性78%,特异性80%)。
红旗征与不能漏的情况
- 入组SOFA下降不足25%与死亡风险升高相关(死亡比值比14.87)。
研究设计与关键结果
- 研究类型:基于两项已发表随机对照试验数据的衍生与验证队列分析;衍生队列448例,验证队列199例。
- 衍生队列第1天平均SOFA 6.06±4.07,28天死亡率22.8%;验证队列第1天平均SOFA 7.84±3.39,28天死亡率29.6%。
- 衍生队列中ΔSOFA预测死亡率最早的时间点为第7天,AUROC 0.84(95%CI 0.80-0.89),P<0.001。
- 最佳预测界值为25%变化(敏感性78%,特异性80%);入组SOFA下降不足25%与死亡率升高相关(死亡比值比14.87)。
- 该发现在验证队列中得到确认。
证据类型、等级与局限
- 证据类型:基于两项随机对照试验数据的衍生与验证队列分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为第7天ΔSOFA是有用的28天死亡率早期预后标志物。
- 作者认为第7天ΔSOFA可作为未来脓毒症试验与死亡率并列的终点指标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Since the Sepsis-3 criteria, change in Sequential Organ Failure Assessment (SOFA) score has become a key component of sepsis identification. Thus, it could be argued that reversal of this change (ΔSOFA) may reflect sepsis response and could be used as measure of efficacy in interventional trials. We aimed to assess the predictive performance of ΔSOFA for 28-day mortality.
METHODS: Data from two previously published randomized controlled trials were studied: the first reporting on patients with severe Gram-negative infections as a derivation cohort and the second reporting on patients with ventilator-associated pneumonia as a validation cohort. Only patients with sepsis according to the Sepsis-3 definition were included in this analysis. SOFA scores were calculated on days 1, 2, 3, 5, 7, 14, and 28.
RESULTS: We included 448 patients within the derivation cohort and 199 within the validation cohort. Mean SOFA scores on day 1 were 6.06 ± 4.07 and 7.84 ± 3.39, and 28 day mortality 22.8% and 29.6%, respectively. In the derivation cohort, the earliest time point where ΔSOFA score predicted mortality was day 7 (AUROC (95% CI) 0.84 (0.80-0.89); p < 0.001). The best tradeoff for prediction was found with 25% changes (78% sensitivity, 80% specificity); less than 25% decrease of admission SOFA was associated with increased mortality (odds ratio for death 14.87). This finding was confirmed in the validation cohort.
CONCLUSIONS: ΔSOFA on day 7 is a useful early prognostic marker of 28-day mortality and could serve as an endpoint in future sepsis trials alongside mortality.
TRIAL REGISTRATION: ClinicalTrials.gov numbers NCT01223690 and NCT00297674.
参考来源
- Karakike E, Kyriazopoulou E, Tsangaris I, et al. The early change of SOFA score as a prognostic marker of 28-day sepsis mortality: analysis through a derivation and a validation cohort. Crit Care. 2019. PMID: 31783881. doi:10.1186/s13054-019-2665-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。